Methods Study to Evaluate Use of Cardiac Ultrasound to Assess Heart Valve Abnormality in People.

Pfizer

Status: Completed

Conditions: Heart Valve Diseases

Treatments: Device: cardiac echosonography

Study type: Observational

Funder types: Industry

Identifiers

NCT00359489

A9001336

Details and patient eligibility

About

Methods study to evaluate use of cardiac ultrasound to assess heart valve abnormality in people.

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• >=18 years of age subjects with stable concomitant diseases with BMI >=30 kg/m2

Exclusion criteria

• Pregnant females
• Those with unstable/new onset diseases
• Those who are on agents known to be associated with cardiac valvular heart disease